Research Paper Volume 15, Issue 20 pp 10996—11011
BTN2A2, a new biomarker and therapeutic target for glioma
Figure 6. GSEA of BTN2A2 in glioma. (A–I) The CTLA4, MHC, Th1-Th2, chemokine, and JAK-STAT signaling pathway, the processing and presentation of antigens, and apoptosis were determined using GSEA.